Medical diagnostics company Universal Biosensors (ASX:UBI) has announced the launch of the OneTouch Verio in Italy and France.
The OneTouch Verio is a diabetes self-monitoring product which Universal Biosensors helped develop for LifeScan.
UBI shares grew 1% in Tuesday's trading to $1.520.
Join the CIO Australia group on LinkedIn. The group is open to CIOs, IT Directors, COOs, CTOs and senior IT managers.